Form 8-K - Current report:
SEC Accession No. 0001628280-25-022400
Filing Date
2025-05-06
Accepted
2025-05-06 07:36:54
Documents
16
Period of Report
2025-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bvs-20250506.htm   iXBRL 8-K 33553
2 EX-99.1 bioventusex-991q12025.htm EX-99.1 287842
7 image_0a.jpg GRAPHIC 50612
  Complete submission text file 0001628280-25-022400.txt   578589

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bvs-20250506.xsd EX-101.SCH 2038
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bvs-20250506_def.xml EX-101.DEF 15409
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bvs-20250506_lab.xml EX-101.LAB 27075
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bvs-20250506_pre.xml EX-101.PRE 16123
18 EXTRACTED XBRL INSTANCE DOCUMENT bvs-20250506_htm.xml XML 2919
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 25915267
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)